GSK and MSD to compete vaccines in Korea.

Published: 2007-03-02 07:00:00

Updated: 2007-03-02 07:00:00

Two leading vaccine manufacturers, GSK and MSD, may stage severe market competition with the cervical cancer and rotavirus vaccines in the world markets as well as Korea market during the times from the 2nd half of this year to the next year.

MSD plans to launch Gardasil (cervix cancer vaccin...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK